902 related articles for article (PubMed ID: 24966597)
1. Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: An update.
Elpek GÖ
World J Gastroenterol; 2014 Jun; 20(23):7260-76. PubMed ID: 24966597
[TBL] [Abstract][Full Text] [Related]
2. Recent advancement of molecular mechanisms of liver fibrosis.
Seki E; Brenner DA
J Hepatobiliary Pancreat Sci; 2015 Jul; 22(7):512-8. PubMed ID: 25869468
[TBL] [Abstract][Full Text] [Related]
3. Expression of hepatic stellate cell activation-related genes in HBV-, HCV-, and nonalcoholic fatty liver disease-associated fibrosis.
He L; Yuan H; Liang J; Hong J; Qu C
PLoS One; 2020; 15(5):e0233702. PubMed ID: 32442221
[TBL] [Abstract][Full Text] [Related]
4. Cellular mechanisms of tissue fibrosis. 5. Novel insights into liver fibrosis.
Mallat A; Lotersztajn S
Am J Physiol Cell Physiol; 2013 Oct; 305(8):C789-99. PubMed ID: 23903700
[TBL] [Abstract][Full Text] [Related]
5. Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets.
Zhang CY; Yuan WG; He P; Lei JH; Wang CX
World J Gastroenterol; 2016 Dec; 22(48):10512-10522. PubMed ID: 28082803
[TBL] [Abstract][Full Text] [Related]
6. Molecular interplays in hepatic stellate cells: apoptosis, senescence, and phenotype reversion as cellular connections that modulate liver fibrosis.
de Oliveira da Silva B; Ramos LF; Moraes KCM
Cell Biol Int; 2017 Sep; 41(9):946-959. PubMed ID: 28498509
[TBL] [Abstract][Full Text] [Related]
7. Hedgehog-YAP Signaling Pathway Regulates Glutaminolysis to Control Activation of Hepatic Stellate Cells.
Du K; Hyun J; Premont RT; Choi SS; Michelotti GA; Swiderska-Syn M; Dalton GD; Thelen E; Rizi BS; Jung Y; Diehl AM
Gastroenterology; 2018 Apr; 154(5):1465-1479.e13. PubMed ID: 29305935
[TBL] [Abstract][Full Text] [Related]
8. LPS-induced TNF-α factor mediates pro-inflammatory and pro-fibrogenic pattern in non-alcoholic fatty liver disease.
Ceccarelli S; Panera N; Mina M; Gnani D; De Stefanis C; Crudele A; Rychlicki C; Petrini S; Bruscalupi G; Agostinelli L; Stronati L; Cucchiara S; Musso G; Furlanello C; Svegliati-Baroni G; Nobili V; Alisi A
Oncotarget; 2015 Dec; 6(39):41434-52. PubMed ID: 26573228
[TBL] [Abstract][Full Text] [Related]
9. Inflammation and fibrosis in chronic liver diseases including non-alcoholic fatty liver disease and hepatitis C.
Tanwar S; Rhodes F; Srivastava A; Trembling PM; Rosenberg WM
World J Gastroenterol; 2020 Jan; 26(2):109-133. PubMed ID: 31969775
[TBL] [Abstract][Full Text] [Related]
10. Reversal of liver cirrhosis: current evidence and expectations.
Jung YK; Yim HJ
Korean J Intern Med; 2017 Mar; 32(2):213-228. PubMed ID: 28171717
[TBL] [Abstract][Full Text] [Related]
11. Hepatic fibrosis: It is time to go with hepatic stellate cell-specific therapeutic targets.
Ezhilarasan D; Sokal E; Najimi M
Hepatobiliary Pancreat Dis Int; 2018 Jun; 17(3):192-197. PubMed ID: 29709350
[TBL] [Abstract][Full Text] [Related]
12. Hepatic stellate cells role in the course of metabolic disorders development - A molecular overview.
Bourebaba N; Marycz K
Pharmacol Res; 2021 Aug; 170():105739. PubMed ID: 34171492
[TBL] [Abstract][Full Text] [Related]
13. Fibromodulin, an oxidative stress-sensitive proteoglycan, regulates the fibrogenic response to liver injury in mice.
Mormone E; Lu Y; Ge X; Fiel MI; Nieto N
Gastroenterology; 2012 Mar; 142(3):612-621.e5. PubMed ID: 22138190
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of Fibrosis Development in Nonalcoholic Steatohepatitis.
Schwabe RF; Tabas I; Pajvani UB
Gastroenterology; 2020 May; 158(7):1913-1928. PubMed ID: 32044315
[TBL] [Abstract][Full Text] [Related]
15. Role of G Protein-Coupled Receptors in Hepatic Stellate Cells and Approaches to Anti-Fibrotic Treatment of Non-Alcoholic Fatty Liver Disease.
Kimura T; Singh S; Tanaka N; Umemura T
Front Endocrinol (Lausanne); 2021; 12():773432. PubMed ID: 34938271
[TBL] [Abstract][Full Text] [Related]
16. ECM1 Prevents Activation of Transforming Growth Factor β, Hepatic Stellate Cells, and Fibrogenesis in Mice.
Fan W; Liu T; Chen W; Hammad S; Longerich T; Hausser I; Fu Y; Li N; He Y; Liu C; Zhang Y; Lian Q; Zhao X; Yan C; Li L; Yi C; Ling Z; Ma L; Zhao X; Xu H; Wang P; Cong M; You H; Liu Z; Wang Y; Chen J; Li D; Hui L; Dooley S; Hou J; Jia J; Sun B
Gastroenterology; 2019 Nov; 157(5):1352-1367.e13. PubMed ID: 31362006
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of hepatic fibrogenesis.
Lee UE; Friedman SL
Best Pract Res Clin Gastroenterol; 2011 Apr; 25(2):195-206. PubMed ID: 21497738
[TBL] [Abstract][Full Text] [Related]
18. Enhanced expression of BMP6 inhibits hepatic fibrosis in non-alcoholic fatty liver disease.
Arndt S; Wacker E; Dorn C; Koch A; Saugspier M; Thasler WE; Hartmann A; Bosserhoff AK; Hellerbrand C
Gut; 2015 Jun; 64(6):973-81. PubMed ID: 25011936
[TBL] [Abstract][Full Text] [Related]
19. Recent Insight into the Role of Fibrosis in Nonalcoholic Steatohepatitis-Related Hepatocellular Carcinoma.
Sircana A; Paschetta E; Saba F; Molinaro F; Musso G
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30970564
[TBL] [Abstract][Full Text] [Related]
20. [Cellular mechanism in the fibrogenesis of liver fibrosis].
You H; Sun YM
Zhonghua Gan Zang Bing Za Zhi; 2012 Aug; 20(8):563-4. PubMed ID: 23227528
[No Abstract] [Full Text] [Related]
[Next] [New Search]
